Infectious Disease Epidemiology and Dynamics Achievement list
2025
Wang C, Lai X, Abbas K, Pouwels KB, Zhang H, Jit M, Fang H. (2025). Health impact and economic evaluation of the Expanded Program on Immunization in China from 1974 to 2024: a modelling study. Lancet Public Health, S2468-2667(25)00039-8. https://doi.org/10.1016/s2468-2667(25)00039-8
Han, S. M., Shiino, T., Masuda, S., Furuse, Y., Yasaka, T., Kanda, S., Komori, K., Saito, N., Kubo, Y., Smith, C., Endo, A., Robert, A., Baguelin, M., & Ariyoshi, K. (2025). Phylogenetic Study of Local Patterns Influenza A(H3N2) Virus Transmission in a Semi‐Isolated Population in a Remote Island in Japan Between 2011 and 2013. Influenza and Other Respiratory Viruses, 19(3), e70089. https://doi.org/10.1111/irv.70089
Han, S. M., Kubo, Y., Robert, A., Baguelin, M., & Ariyoshi, K. (2025). Impact of Viral Co-Detection on the Within-Host Viral Diversity of Influenza Patients. Viruses, 17(2), 152. https://doi.org/10.3390/v17020152
Kim, S., Kang, H., Skrip, L., Sahastrabuddhe, S., Islam, A., Jung, S.-M., Vesga, J. F., Endo, A., Edmunds, W. J., & Abbas, K. (2025). Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response. Expert Review of Vaccines, 24(1), 183–193. https://doi.org/10.1080/14760584.2025.2476523
A, J., Gan, G., Endo, A., Jin Tan, R. K., Prem, K., & Dickens, B. L. (2025). Is Southeast Asia and the Western Pacific ready for potential monkeypox virus outbreaks? The Lancet Regional Health - Western Pacific, 57, 101526. https://doi.org/10.1016/j.lanwpc.2025.101526
Auzenbergs, M., Abbas, K., Peak, C. M., Voorman, A., Jit, M., & O’Reilly, K. M. (2025). Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysis. BMJ Global Health, 10(3), e016013. https://doi.org/10.1136/bmjgh-2024-016013
Lim A, Shearer FM, Sewalk K, Pigott DM, Clarke J, Ghouse A, Judge C, Kang H, Messina JP, Kraemer MUG, Gaythorpe KAM, de Souza WM, Nsoesie EO, Celone M, Faria N, Ryan SJ, Rabe IB, Rojas DP, Hay SI, Brownstein JS, Golding N, Brady OJ. (2025). The overlapping global distribution of dengue, chikungunya, Zika and yellow fever. Nature Communications, 16(1):3418. https://doi.org/10.1038/s41467-025-58609-5
2024
Kang, H., Auzenbergs, M., Clapham, H., Maure, C., Kim, J.-H., Salje, H., Taylor, C. G., Lim, A., Clark, A., Edmunds, W. J., Sahastrabuddhe, S., Brady, O. J., & Abbas, K. (2024). Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, S1473309923008101. https://doi.org/10.1016/S1473-3099(23)00810-1
Auzenbergs, M., Maure, C., Kang, H., Clark, A., Brady, O., Sahastrabuddhe, S., & Abbas, K. (2024). Programmatic considerations and evidence gaps for chikungunya vaccine introduction in countries at risk of chikungunya outbreaks: Stakeholder analysis. PLOS Neglected Tropical Diseases, 18(4), e0012075. https://doi.org/10.1371/journal.pntd.0012075
Maure, C., Khazhidinov, K., Kang, H., Auzenbergs, M., Moyersoen, P., Abbas, K., Santos, G. M. L., Medina, L. M. H., Wartel, T. A., Kim, J. H., Clemens, J., & Sahastrabuddhe, S. (2024). Chikungunya vaccine development, challenges, and pathway toward public health impact. Vaccine, 42(26), 126483. https://doi.org/10.1016/j.vaccine.2024.126483
Flandes, X., Hansen, C. A., Palani, S., Abbas, K., Bennett, C., Caro, W. P., Hutubessy, R., Khazhidinov, K., Lambach, P., Maure, C., Marshall, C., Rojas, D. P., Rosewell, A., Sahastrabuddhe, S., Tufet, M., Wilder-Smith, A., Beasley, D. W. C., Bourne, N., & Barrett, A. D. T. (2024). Vaccine value profile for Chikungunya. Vaccine. https://doi.org/10.1016/j.vaccine.2023.07.069
Mogasale, V. V., Sinha, A., John, J., Hasan Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A., & Abbas, K. (2024). Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. BMJ Public Health, 2(2), e001089. https://doi.org/10.1136/bmjph-2024-001089
Mogasale, V. V., Sinha, A., John, J., Hasan Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Gopal Dhoubhadel, B., John Edmunds, W., Clark, A., & Abbas, K. (2024). Typhoid conjugate vaccine implementation in India: A review of supportive evidence. Vaccine: X, 21, 100568. https://doi.org/10.1016/j.jvacx.2024.100568
Williams, S. V., Akande, T., & Abbas, K. (2024). Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria. PLOS ONE, 19(3), e0297326. https://doi.org/10.1371/journal.pone.0297326
Abbas, K., Yoo, K. J., Prem, K., & Jit, M. (2024). Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010–22: a modelling study. EClinicalMedicine, 102524. https://doi.org/10.1016/j.eclinm.2024.102524
Hartner, A.-M., Li, X., Echeverria-Londono, S., Roth, J., Abbas, K., Auzenbergs, M., De Villiers, M. J., Ferrari, M. J., Fraser, K., Fu, H., Hallett, T., Hinsley, W., Jit, M., Karachaliou, A., Moore, S. M., Nayagam, S., Papadopoulos, T., Perkins, T. A., Portnoy, A., … Gaythorpe, K. A. M. (2024). Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study. The Lancet Global Health, 12(4), e563–e571. https://doi.org/10.1016/S2214-109X(23)00603-4
Parajulee, P., Lee, J.-S., Abbas, K., Cannon, J., Excler, J. L., Kim, J. H., & Mogasale, V. (2024). State transitions across the Strep A disease spectrum: scoping review and evidence gaps. BMC Infectious Diseases, 24(1), 108. https://doi.org/10.1186/s12879-023-08888-4
Shankar M, Hartner AM, Arnold CRK, Gayawan E, Kang H, Kim JH, Gilani GN, Cori A, Fu H, Jit M, Muloiwa R, Portnoy A, Trotter C, Gaythorpe KAM. (2024). How mathematical modelling can inform outbreak response vaccination. BMC Infect Dis 24, 1371. https://doi.org/10.1186/s12879-024-10243-0
2023
Qian, G. Y., Jombart, T., & John Edmunds, W. (2023). Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: A modelling study. Vaccine: X, 14, 100321. https://doi.org/10.1016/j.jvacx.2023.100321
Qian, G. Y., Edmunds, W. J., Bausch, D. G., & Jombart, T. (2023). A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control. BMC Medicine, 21(1), 439. https://doi.org/10.1186/s12916-023-03108-x
Murayama, H., Endo, A., & Yonekura, S. (2023). Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics. Epidemics, 45, 100726. https://doi.org/10.1016/j.epidem.2023.100726
Cadarette, D., Ferranna, M., Cannon, J. W., Abbas, K., Giannini, F., Zucker, L., & Bloom, D. E. (2023). The full health, economic, and social benefits of prospective Strep A vaccination. Npj Vaccines, 8(1), 1–9. https://doi.org/10.1038/s41541-023-00758-z
Fu, H., Abbas, K., Malvolti, S., Gregory, C., Ko, M., Amorij, J.-P., & Jit, M. (2023). Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ Global Health, 8(11), e012204. https://doi.org/10.1136/bmjgh-2023-012204
